Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Type 3 inflammation–specific keratinocyte glutaminolysis promotes skin inflammation
Yongfei Hu, Hai Yu, Kaiyu Liang, Liyan Yuan, Wenjun Zhang, Zhe Zhuang, Suyun Ji, Xichun Xia
Yongfei Hu, Hai Yu, Kaiyu Liang, Liyan Yuan, Wenjun Zhang, Zhe Zhuang, Suyun Ji, Xichun Xia
View: Text | PDF
Research Article Dermatology Metabolism

Type 3 inflammation–specific keratinocyte glutaminolysis promotes skin inflammation

  • Text
  • PDF
Abstract

Inflammatory cytokines reprogram keratinocyte metabolism, but the metabolic pathways that couple immune signals to pathological epidermal growth remain incompletely defined. Here, we identify glutaminase 1–mediated (GLS1-mediated) glutaminolysis as a metabolic program preferentially induced in keratinocytes under type 3 inflammatory conditions. Integrated transcriptomic, metabolomic, genetic, and functional analyses showed that IL-17A induced GLS1 expression and glutaminolysis in keratinocytes. Keratinocyte-specific Gls1 deletion reduced the intracellular availability of arginine, proline, and methionine, impaired amino acid–dependent mTORC1 activation, disrupted redox homeostasis, and limited keratinocyte proliferation. Amino acid or antioxidant supplementation partially rescued these defects, whereas rapamycin blocked the amino acid–mediated proliferative rescue. Gls1 deletion did not impair steady-state skin development or homeostasis and did not alter MC903-induced type 2 dermatitis, but it delayed wound re-epithelialization and attenuated imiquimod-induced psoriasiform inflammation. Loss of keratinocyte GLS1 also reduced epidermal chemokine expression and the accumulation of neutrophils and IL-17A–producing γδ T cells, revealing a role for glutaminolysis in amplifying epithelial-immune crosstalk. These findings define GLS1-mediated glutaminolysis as a context-specific metabolic checkpoint linking type 3 inflammation to keratinocyte proliferation and cutaneous immune amplification, and support locally or temporally controlled GLS1 inhibition as a potential therapeutic strategy for psoriasis.

Authors

Yongfei Hu, Hai Yu, Kaiyu Liang, Liyan Yuan, Wenjun Zhang, Zhe Zhuang, Suyun Ji, Xichun Xia

×

Figure 4

Keratinocyte-specific Gls1 deletion does not disrupt normal skin development or homeostasis.

Options: View larger image (or click on image) Download as PowerPoint
Keratinocyte-specific Gls1 deletion does not disrupt normal skin develop...
(A) Immunostaining of GLS1 in skin from 1-week-old WT and cKO mice. GLS1 staining is absent in epidermis from cKO mice. (B) Histologic sections (H&E stained) of skin from 1-week- and 2-month-old WT and cKO mice show no histologic differences between the mice. (C) Quantification of epidermal thickness, dermal white adipose tissue (dWAT) thickness, and hair follicle number per 1-cm dorsal skin section in 2-month-old WT and cKO mice. (D) Left: Keratin 10 (K10) and K14 mRNA levels in harvested epidermis of 1-week-old WT (n = 6) and cKO (n = 6) mice. Right: K10 and K14 protein expression in the epidermis of 1-week-old WT (n = 3) and cKO (n = 3) mice. (E) Immunohistochemistry for K10 and K14 shows no differences in the respective suprabasal and basal expression for the epidermal keratins between 1-week-old WT and cKO mice. (F) RT-PCR measurement of adhesion genes in the epidermis of 1-week-old WT (n = 6) and cKO (n = 6) mice. (G) Toluidine blue staining of E18.5 embryos indicated no differences in epidermal permeability between WT (n = 3) and cKO (n = 3) mice. (H) Neonatal WT (n = 5) and cKO (n = 5) mouse littermates showed no differences in weight loss, suggesting transepidermal water loss was intact. (I) RT-PCR measurement of the indicated redox genes in basal keratinocytes of 1-week-old WT (n = 6) and cKO (n = 6) mice. (J) Western blot analysis of mTORC1 activation in basal keratinocytes of 1-week-old WT (n = 3) and cKO (n = 3) mice. Scale bars: 20 μm (A), 100 μm (B [low-magnification images]), and 25 μm (B [high-magnification images] and E). Data are presented as mean ± SD and representative of 2 independent experiments with consistent results. Statistical significance was determined by 2-tailed Student’s t test (C, D, F, and I) or 2-way repeated-measures ANOVA followed by Šídák’s multiple-comparison test (H).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts